Bioinformatics analysis of publicly available data from the TCGA database confirmed statistically significant higher levels of BIRC2 (p = 0.0213), BIRC3 (p = 0.0029), BIRC5 (p = 0.0040) gene expression in breast cancer patients under 51 years of age. This evidence concerns the gene BIRC2 and breast carcinoma.